• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

2-Hydrazinyl-6-(Trifluoromethoxy)-1,3-Benzothiazole: A Comprehensive Overview

2-Hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole (CAS No. 133840-98-9) is a versatile compound with significant potential in various fields of chemistry and pharmacology. This compound, characterized by its unique structural features, has garnered considerable attention for its applications in drug discovery, chemical synthesis, and biological research. In this article, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the study of 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole.

Chemical Structure and Properties:

2-Hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole is a heterocyclic compound that belongs to the class of benzothiazoles. The presence of the hydrazinyl group and the trifluoromethoxy substituent imparts unique chemical and physical properties to this molecule. The hydrazinyl group is known for its reactivity in various organic reactions, making it a valuable building block in synthetic chemistry. The trifluoromethoxy group, on the other hand, enhances the lipophilicity and metabolic stability of the molecule, which are crucial factors in drug design.

The molecular formula of 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole is C₉H₇F₃N₄O_S, with a molecular weight of approximately 258.22 g/mol. The compound exhibits good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), which facilitates its use in various chemical reactions and biological assays.

Synthesis Methods:

The synthesis of 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole has been reported using several methodologies. One common approach involves the reaction of 6-(trifluoromethoxy)-1,3-benzothiazol-2(3H)-one with hydrazine hydrate under appropriate conditions. This reaction typically proceeds via a nucleophilic addition followed by a cyclization step to form the desired product. Another method involves the condensation of 6-(trifluoromethoxy)benzothiazole-2-thiol with hydrazine to yield the target compound.

The choice of synthetic route depends on factors such as yield, purity, and scalability. Recent advancements in green chemistry have also led to the development of more environmentally friendly methods for synthesizing this compound. For instance, microwave-assisted synthesis has been shown to significantly reduce reaction times and improve yields while minimizing waste generation.

Biological Activities:

2-Hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole has demonstrated a range of biological activities that make it an attractive candidate for pharmaceutical research. One of its most notable properties is its antitumor activity. Studies have shown that this compound can inhibit the growth of various cancer cell lines by inducing apoptosis and cell cycle arrest. The mechanism of action is believed to involve the modulation of key signaling pathways such as PI3K/Akt and MAPK/ERK.

In addition to its antitumor effects, 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole has also been investigated for its antimicrobial properties. Research has indicated that this compound exhibits potent activity against both Gram-positive and Gram-negative bacteria, making it a potential lead for developing new antibiotics. The antimicrobial activity is thought to be mediated by disrupting bacterial cell wall synthesis or interfering with essential metabolic processes.

Clinical Applications:

The promising biological activities of 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole have spurred interest in its potential clinical applications. Preclinical studies have shown that this compound can effectively inhibit tumor growth in animal models without significant toxicity. These findings have paved the way for further clinical trials to evaluate its safety and efficacy in human subjects.

In parallel with its antitumor potential, there is growing interest in exploring the use of 2-hydrazinyl-6-(trifluoromethoxy)-1,3-benzothiazole strong > as an antimicrobial agent. Given the increasing prevalence of antibiotic-resistant bacteria, compounds like this could play a crucial role in addressing this global health challenge.

CURRENT RESEARCH TRENDS AND FUTURE PERSPECTIVES:

CURRENT RESEARCH ON 2-HYDRAZINYL-6-(TRIFLUOROMETHOXY)-1 , 3-BENZOTHIAZOLE IS FOCUSING ON SEVERAL KEY AREAS . ONE OF THE MAJOR AREAS OF INVESTIGATION IS THE OPTIMIZATION OF ITS PHARMACOLOGICAL PROPERTIES THROUGH STRUCTURAL MODIFICATIONS . SCIENTISTS ARE EXPLORING THE EFFECTS OF VARYING SUBSTITUENTS ON THE HYDRAZINYL AND TRIFLUOROMETHOXY GROUPS TO ENHANCE SELECTIVITY AND POTENCY . ADDITIONALLY , EFFORTS ARE BEING MADE TO IMPROVE THE BIOAVAILABILITY AND PHARMACOKINETIC PROPERTIES OF THIS COMPOUND FOR BETTER THERAPEUTIC OUTCOMES .

FURTHERMORE , THE DEVELOPMENT OF NOVEL DELIVERY SYSTEMS SUCH AS NANOPARTICLES AND LIPOSOMES IS BEING EXPLORED TO ENHANCE THE EFFICACY AND REDUCE THE TOXICITY OF 2-HYDRAZINYL-6-(TRIFLUOROMETHOXY)-1 , 3-BENZOTHIAZOLE . THESE ADVANCEMENTS COULD LEAD TO MORE TARGETED AND EFFICIENT TREATMENTS FOR VARIOUS DISEASES .

THERE IS ALSO A GROWING INTEREST IN UNDERSTANDING THE MOLECULAR MECHANISMS UNDERLYING THE BIOLOGICAL ACTIVITIES OF 2-HYDRAZINYL-6-(TRIFLUOROMETHOXY)-1 , 3-BENZOTHIAZOLE . GENOMIC AND PROTEOMIC STUDIES ARE BEING CONDUCTED TO IDENTIFY THE SPECIFIC TARGETS AND PATHWAYS INVOLVED IN ITS ACTION . THIS KNOWLEDGE WILL BE CRUCIAL FOR DEVELOPING RATIONAL DESIGN STRATEGIES FOR NEW DRUGS BASED ON THIS COMPOUND .

• 130997-61-4((2Z)-3-ethyl-6-(trifluoromethoxy)-1,3-benzothiazol-2(3H)-imine hydrochloride)
• 776276-53-0(2(3H)-Benzothiazolone,4-methoxy-3-methyl-, hydrazone)
• 13545-66-9(2(3H)-Benzothiazolone,6-methoxy-3-methyl-, 2-(3-methyl-2(3H)-benzothiazolylidene)hydrazone)
• 130997-59-0(2(3H)-Benzothiazolimine,3-methyl-6-(trifluoromethoxy)-)
• 20065-05-8(2(3H)-Benzothiazolone, 6-ethoxy-3-methyl-, hydrazone)
• 191720-08-8(2(3H)-BENZOTHIAZOLIMINE, 3-[(METHYLTHIO)METHYL]-6-(TRIFLUOROMETHOXY)-)
• 13545-99-8(2-Hydrazinylidene-6-methoxy-3-methyl-2,3-dihydro-1,3-benzothiazole)
• 130569-80-1(2(3H)-BENZOTHIAZOLIMINE, 3-[(METHYLSULFINYL)METHYL]-6-(TRIFLUOROMETHOXY)-)
• 110274-77-6(2(3H)-Benzothiazolone, 5-methoxy-3-methyl-, hydrazone)
• 382627-87-4